These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21147217)

  • 21. Variable inhibitory effects on the formation of dinitrosyl iron complexes by deferoxamine and salicylaldehyde isonicotinoyl hydrazone in K562 cells.
    Meczynska S; Lewandowska H; Sochanowicz B; Sadlo J; Kruszewski M
    Hemoglobin; 2008; 32(1-2):157-63. PubMed ID: 18274993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Designing salicylaldehyde isonicotinoyl hydrazones as Cu(II) ionophores with tunable chelation and release of copper for hitting redox Achilles heel of cancer cells.
    Ji Y; Dai F; Zhou B
    Free Radic Biol Med; 2018 Dec; 129():215-226. PubMed ID: 30240704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The interaction of pyridoxal isonicotinoyl hydrazone (PIH) and salicylaldehyde isonicotinoyl hydrazone (SIH) with iron.
    Chen YL; Kong X; Xie Y; Hider RC
    J Inorg Biochem; 2018 Mar; 180():194-203. PubMed ID: 29329026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unprecedented oxidation of a biologically active aroylhydrazone chelator catalysed by iron(III): serendipitous identification of diacylhydrazine ligands with high iron chelation efficacy.
    Bernhardt PV; Chin P; Richardson DR
    J Biol Inorg Chem; 2001 Oct; 6(8):801-9. PubMed ID: 11713687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct administration of rutin does not protect against catecholamine cardiotoxicity.
    Mladenka P; Zatloukalová L; Simůnek T; Bobrovová Z; Semecký V; Nachtigal P; Hasková P; Macková E; Vávrová J; Holecková M; Palicka V; Hrdina R
    Toxicology; 2009 Jan; 255(1-2):25-32. PubMed ID: 18992299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iron chelators: correlation between effects on Plasmodium spp. and immune functions.
    Golenser J; Domb A; Mordechai-Daniel T; Leshem B; Luty A; Kremsner P
    J Parasitol; 2006 Feb; 92(1):170-7. PubMed ID: 16629332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardioprotective effects of a novel iron chelator, pyridoxal 2-chlorobenzoyl hydrazone, in the rabbit model of daunorubicin-induced cardiotoxicity.
    Sterba M; Popelová O; Simunek T; Mazurová Y; Potácová A; Adamcová M; Kaiserová H; Ponka P; Gersl V
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1336-47. PubMed ID: 17003229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311.
    Chaston TB; Lovejoy DB; Watts RN; Richardson DR
    Clin Cancer Res; 2003 Jan; 9(1):402-14. PubMed ID: 12538494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The novel iron chelator, 2-pyridylcarboxaldehyde 2-thiophenecarboxyl hydrazone, reduces catecholamine-mediated myocardial toxicity.
    Mladĕnka P; Kalinowski DS; Haskova P; Bobrovová Z; Hrdina R; Simůnek T; Nachtigal P; Semecký V; Vávrová J; Holeckova M; Palicka V; Mazurová Y; Jansson PJ; Richardson DR
    Chem Res Toxicol; 2009 Jan; 22(1):208-17. PubMed ID: 19172757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potent antitumor activity of novel iron chelators derived from di-2-pyridylketone isonicotinoyl hydrazone involves fenton-derived free radical generation.
    Chaston TB; Watts RN; Yuan J; Richardson DR
    Clin Cancer Res; 2004 Nov; 10(21):7365-74. PubMed ID: 15534113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-activity relationships of novel iron chelators for the treatment of iron overload disease: the methyl pyrazinylketone isonicotinoyl hydrazone series.
    Kalinowski DS; Sharpe PC; Bernhardt PV; Richardson DR
    J Med Chem; 2008 Jan; 51(2):331-44. PubMed ID: 18159922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection of human and murine hepatocytes against Fas-induced death by transferrin and iron.
    Lesnikov VA; Abbasi N; Lesnikova MP; Lazaro CA; Campbell JS; Fausto N; Deeg HJ
    Apoptosis; 2006 Jan; 11(1):79-87. PubMed ID: 16374550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of catecholamine oxidation in sudden cardiac death.
    Dhalla NS; Adameova A; Kaur M
    Fundam Clin Pharmacol; 2010 Oct; 24(5):539-46. PubMed ID: 20584205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iron-chelator complexes as iron sources for early developing human erythroid precursors.
    Leimberg JM; Prus E; Link G; Fibach E; Konijn AM
    Transl Res; 2008 Feb; 151(2):88-96. PubMed ID: 18201676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of LIP level and ROS formation through interaction of H-ferritin with G-CSF receptor.
    Yuan X; Cong Y; Hao J; Shan Y; Zhao Z; Wang S; Chen J
    J Mol Biol; 2004 May; 339(1):131-44. PubMed ID: 15123426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LC-UV/MS methods for the analysis of prochelator-boronyl salicylaldehyde isonicotinoyl hydrazone (BSIH) and its active chelator salicylaldehyde isonicotinoyl hydrazone (SIH).
    Bureš J; Jansová H; Stariat J; Filipský T; Mladěnka P; Šimůnek T; Kučera R; Klimeš J; Wang Q; Franz KJ; Kovaříková P
    J Pharm Biomed Anal; 2015 Feb; 105():55-63. PubMed ID: 25527982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective Effects of D-Penicillamine on Catecholamine-Induced Myocardial Injury.
    Říha M; Hašková P; Martin J; Filipský T; Váňová K; Vávrová J; Holečková M; Homola P; Vítek L; Palicka V; Šimůnek T; Mladěnka P
    Oxid Med Cell Longev; 2016; 2016():5213532. PubMed ID: 26788248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Examination of diverse iron-chelating agents for the protection of differentiated PC12 cells against oxidative injury induced by 6-hydroxydopamine and dopamine.
    Hašková P; Applová L; Jansová H; Homola P; Franz KJ; Vávrová K; Roh J; Šimůnek T
    Sci Rep; 2022 Jun; 12(1):9765. PubMed ID: 35697900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phloroglucinol (1,3,5-trihydroxybenzene) protects against ionizing radiation-induced cell damage through inhibition of oxidative stress in vitro and in vivo.
    Kang KA; Zhang R; Chae S; Lee SJ; Kim J; Kim J; Jeong J; Lee J; Shin T; Lee NH; Hyun JW
    Chem Biol Interact; 2010 May; 185(3):215-26. PubMed ID: 20188716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute toxicity of hexavalent chromium in isolated teleost hepatocytes.
    Krumschnabel G; Nawaz M
    Aquat Toxicol; 2004 Nov; 70(2):159-67. PubMed ID: 15522432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.